• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Aging (Albany NY) . Differentially expressed immune response genes in COVID-19 patients based on disease severity

tetano

Editor, Senior Moderator
Aging (Albany NY)


. 2021 Mar 29;13.
doi: 10.18632/aging.202877. Online ahead of print.
Differentially expressed immune response genes in COVID-19 patients based on disease severity


Shasha Li[SUP] 1 2 [/SUP], Xiaoqiong Duan[SUP] 3 [/SUP], Yujia Li[SUP] 3 [/SUP], Ming Li[SUP] 1 2 [/SUP], Yong Gao[SUP] 2 4 [/SUP], Tuantuan Li[SUP] 2 4 [/SUP], Shilin Li[SUP] 3 [/SUP], Lin Tan[SUP] 1 2 [/SUP], Tuo Shao[SUP] 5 [/SUP], Andre J Jeyarajan[SUP] 5 [/SUP], Limin Chen[SUP] 3 [/SUP], Mingfeng Han[SUP] 2 6 [/SUP], Wenyu Lin[SUP] 5 [/SUP], Xiuyong Li[SUP] 2 7 [/SUP]



Affiliations

Abstract

Background: Dysregulated immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are thought to underlie the progression of coronavirus disease 2019 (COVID-19). We sought to further characterize host antiviral and cytokine gene expression in COVID-19 patients based on illness severity.
Methods: In this case-control study, we retrospectively analyzed 46 recovered COVID-19 patients and 24 healthy subjects (no history of COVID-19) recruited from the Second People's Hospital of Fuyang City. Blood samples were collected from each study participant for RNA extraction and PCR. We assessed changes in antiviral gene expression between healthy controls and patients with mild/moderate (MM) and severe/critical (SC) disease.
Results: We found that type I interferon signaling (IFNA2, TLR8, IFNA1, IFNAR1, TLR9, IRF7, ISG15, APOBEC3G, and MX1) and genes encoding proinflammatory cytokines (IL12B, IL15, IL6, IL12A and IL1B) and chemokines (CXCL9, CXCL11 and CXCL10) were upregulated in patients with MM and SC disease. Moreover, we found that IFNA1, apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G (APOBEC3G), and Fas-associated protein with death domain (FADD) were significantly downregulated (P < 0.05) in the SC group compared to the MM group. We also observed that microRNA (miR)-155 and miR-130a levels were markedly higher in the MM group compared to the SC group.
Conclusion: COVID-19 is associated with the activation of host antiviral genes. Induction of the IFN system appears to be particularly important in controlling SARS-CoV-2 infection, as decreased expression of IFNA1, APOBEC3G and FADD genes in SC patients, relative to MM patients, may be associated with disease progression.

Keywords: APOBEC3G; COVID-19; IL6; SARS-CoV-2; immune response genes.
 
Back
Top Bottom